Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Cash flows from operating activities:
Net income	$ 126,337	$ (42,091)
Adjustments to reconcile net income/(loss) to net cash provided by operating activities:
Stock-based compensation	16,696	16,939
Depreciation and amortization	11,611	13,235
Loss on disposal of fixed assets	449	473
Impairment of intangibles		42,528
Impairment of lease right-of-use asset and fixed assets	1,089	36,896
Deferred taxes	452	(17,509)
Accrued interest on note receivable - related party	(18)	(24)
Change in valuation of contingent considerations	7,834	(5,020)
Gain (Loss) on Disposition of Intangible Assets	(8,000)
Recovery of receivables, related to the Payless ShoeSource bankruptcy	(919)	0
Changes, net of acquisitions, in:
Accounts receivable	(10,561)	4,640
Increase (Decrease) in Accounts and Other Receivables	95,077	16,405
Notes receivable - related party	307	308
Inventories	(99,778)	27,213
Prepaid expenses, income tax receivables, prepaid taxes, and other current assets	(2,638)	7,691
Accounts payable and accrued expenses	143,111	(54,156)
Accrued incentive compensation	8,961	(7,319)
Leases and other liabilities	(3,672)	(6,792)
Net cash provided by operating activities	96,184	607
Cash flows from investing activities:
Capital expenditures	4,599	5,496
Proceeds from Sale of Intangible Assets	8,000
Payments to Acquire Short-term Investments	43,376	41,223
Proceeds from Sale of Short-term Investments	42,383	47,243
Net cash provided by investing activities	2,408	524
Cash flows from financing activities:
Tax benefit from the exercise of options	7,232	960
Payments to Noncontrolling Interests		359
Payments of Distributions to Affiliates	(2,859)
Common stock purchased for treasury	(74,685)	(29,796)
Cash dividends paid on common stock	(36,990)	(12,459)
Advances from factor	0	176,784
Repayments of advances from factor	0	(176,784)
Net cash used in financing activities	(126,429)	(40,936)
Effect of Exchange Rate on Cash and Cash Equivalents	(504)	(476)
Net decrease in cash and cash equivalents	(28,341)	(40,281)
Cash and cash equivalents – beginning of period	247,864	264,101
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Total	219,523	$ 223,820
Payments to Acquire Interest in Joint Venture	$ (19,127)